Assembly Biosciences Stock Probability of Future Stock Price Finishing Under 1.33
| ASMB Stock | USD 15.21 0.60 3.80% |
Assembly |
Assembly Biosciences Target Price Odds to finish below 1.33
The tendency of Assembly Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 1.33 or more in 90 days |
| 15.21 | 90 days | 1.33 | near 1 |
Based on a normal probability distribution, the odds of Assembly Biosciences to drop to $ 1.33 or more in 90 days from now is near 1 (This Assembly Biosciences probability density function shows the probability of Assembly Stock to fall within a particular range of prices over 90 days) . Probability of Assembly Biosciences price to stay between $ 1.33 and its current price of $15.21 at the end of the 90-day period is about 19.42 .
Given the investment horizon of 90 days Assembly Biosciences has a beta of 0.62. This suggests as returns on the market go up, Assembly Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Assembly Biosciences will be expected to be much smaller as well. Additionally Assembly Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Assembly Biosciences Price Density |
| Price |
Predictive Modules for Assembly Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Assembly Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Assembly Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Assembly Biosciences is not an exception. The market had few large corrections towards the Assembly Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Assembly Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Assembly Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | 0.62 | |
σ | Overall volatility | 1.15 | |
Ir | Information ratio | -0.04 |
Assembly Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Assembly Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Assembly Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Assembly Biosciences generated a negative expected return over the last 90 days | |
| Assembly Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (61.23 M) with loss before overhead, payroll, taxes, and interest of (63.9 M). | |
| About 32.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: JOSH BERMAN JOINS ASSEMBLY AS EVP, ASSEMBLY LEAD IN NORTH AMERICA |
Assembly Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Assembly Stock often depends not only on the future outlook of the current and potential Assembly Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Assembly Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.6 M | |
| Cash And Short Term Investments | 130.2 M |
Assembly Biosciences Technical Analysis
Assembly Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Assembly Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Assembly Biosciences. In general, you should focus on analyzing Assembly Stock price patterns and their correlations with different microeconomic environments and drivers.
Assembly Biosciences Predictive Forecast Models
Assembly Biosciences' time-series forecasting models is one of many Assembly Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Assembly Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Assembly Biosciences
Checking the ongoing alerts about Assembly Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Assembly Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Assembly Biosciences generated a negative expected return over the last 90 days | |
| Assembly Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (61.23 M) with loss before overhead, payroll, taxes, and interest of (63.9 M). | |
| About 32.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: JOSH BERMAN JOINS ASSEMBLY AS EVP, ASSEMBLY LEAD IN NORTH AMERICA |
Check out Assembly Biosciences Backtesting, Assembly Biosciences Valuation, Assembly Biosciences Correlation, Assembly Biosciences Hype Analysis, Assembly Biosciences Volatility, Assembly Biosciences History as well as Assembly Biosciences Performance. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.89) | Revenue Per Share 4.125 | Quarterly Revenue Growth (1.00) | Return On Assets (0.35) | Return On Equity (1.02) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.